Boone Capital Management
Latest statistics and disclosures from Boone Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDT, MIRM, IONS, CI, BBIO, and represent 50.91% of Boone Capital Management's stock portfolio.
- Added to shares of these 9 stocks: IONS (+$27M), BBIO (+$24M), RAPT (+$20M), CI (+$14M), COGT (+$14M), KOD (+$12M), LIVN (+$8.8M), QURE (+$8.6M), CLPT (+$6.2M).
- Started 8 new stock positions in BBIO, CLPT, IONS, COGT, RAPT, LIVN, KOD, QURE.
- Reduced shares in these 7 stocks: AVTR (-$23M), , PNTG (-$19M), MIRM (-$7.8M), BMRN (-$6.4M), ABEO, NBIX.
- Sold out of its positions in AVTR, PNTG, UNM.
- Boone Capital Management was a net buyer of stock by $49M.
- Boone Capital Management has $305M in assets under management (AUM), dropping by 30.78%.
- Central Index Key (CIK): 0001882053
Tip: Access up to 7 years of quarterly data
Positions held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 16 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medtronic SHS (MDT) | 13.4 | $41M | 429k | 95.24 |
|
|
| Mirum Pharmaceuticals (MIRM) | 12.9 | $39M | -16% | 536k | 73.31 |
|
| Ionis Pharmaceuticals (IONS) | 9.0 | $27M | NEW | 418k | 65.42 |
|
| Cigna Corp (CI) | 7.8 | $24M | +133% | 83k | 288.25 |
|
| Bridgebio Pharma (BBIO) | 7.8 | $24M | NEW | 460k | 51.94 |
|
| Neurocrine Biosciences (NBIX) | 7.7 | $23M | -7% | 166k | 140.38 |
|
| Rapt Therapeutics Com New (RAPT) | 6.6 | $20M | NEW | 783k | 25.79 |
|
| UnitedHealth (UNH) | 6.6 | $20M | 58k | 345.30 |
|
|
| BioMarin Pharmaceutical (BMRN) | 5.8 | $18M | -26% | 329k | 54.16 |
|
| Icon SHS (ICLR) | 5.5 | $17M | 96k | 175.00 |
|
|
| Cogent Biosciences (COGT) | 4.4 | $14M | NEW | 945k | 14.36 |
|
| Kodiak Sciences (KOD) | 3.8 | $12M | NEW | 716k | 16.37 |
|
| Livanova SHS (LIVN) | 2.9 | $8.8M | NEW | 168k | 52.38 |
|
| Uniqure Nv SHS (QURE) | 2.8 | $8.6M | NEW | 147k | 58.37 |
|
| Clearpoint Neuro (CLPT) | 2.0 | $6.2M | NEW | 284k | 21.79 |
|
| Abeona Therapeutics Com New (ABEO) | 0.9 | $2.7M | -59% | 503k | 5.28 |
|
Past Filings by Boone Capital Management
SEC 13F filings are viewable for Boone Capital Management going back to 2022
- Boone Capital Management 2025 Q3 filed Nov. 14, 2025
- Boone Capital Management 2025 Q2 filed Aug. 14, 2025
- Boone Capital Management 2025 Q1 filed May 15, 2025
- Boone Capital Management 2024 Q4 filed Feb. 14, 2025
- Boone Capital Management 2024 Q3 filed Nov. 14, 2024
- Boone Capital Management 2024 Q2 filed Aug. 14, 2024
- Boone Capital Management 2024 Q1 filed May 15, 2024
- Boone Capital Management 2023 Q4 filed Feb. 14, 2024
- Boone Capital Management 2023 Q3 filed Nov. 14, 2023
- Boone Capital Management 2023 Q2 filed Aug. 14, 2023
- Boone Capital Management 2023 Q1 filed May 15, 2023
- Boone Capital Management 2022 Q4 filed Feb. 14, 2023